1. Academic Validation
  2. Aryl nucleoside H-phosphonates. Part 16: synthesis and anti-HIV-1 activity of di-aryl nucleoside phosphotriesters

Aryl nucleoside H-phosphonates. Part 16: synthesis and anti-HIV-1 activity of di-aryl nucleoside phosphotriesters

  • Bioorg Med Chem. 2009 May 1;17(9):3489-98. doi: 10.1016/j.bmc.2009.02.033.
Joanna Romanowska 1 Agnieszka Szymańska-Michalak Jerzy Boryski Jacek Stawiński Adam Kraszewski Roberta Loddo Giuseppina Sanna Gabriella Collu Barbara Secci Paolo La Colla
Affiliations

Affiliation

  • 1 Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznań, Poland.
Abstract

Di-aryl nucleoside phosphotriesters have been explored as a new type of pronucleotides for the purpose of anti-HIV-1 therapy and efficient synthetic protocols, based on H-phosphonate chemistry, have been developed for the preparation of this class of compounds. It was found that anti-HIV-1 activity of the phosphotriesters bearing an Antiviral nucleoside moiety (AZT, ddA) and also ddU was due, at least partially, to intracellular conversion into the corresponding nucleoside 5'-monophosphates, and their efficiency correlated well with the pK(a) values of the aryloxy groups present.

Figures